Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuichiro Doki

Showing results (1-10 of 1,594) with videos related to

Pageof 160
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 27, 2023
[The Fourth Basic Plan for Promotion of Cancer Control]Yuichiro Doki
Nihon Geka Gakkai Zasshi|August 19, 2015
[WORLD WIDE CLINICAL TRIALS FROM JAPAN]Yuichiro Doki
Surgery Today|February 17, 2016
Retraction Note: Notice of formal retraction of articles by Dr. Akihiro ChoYuichiro Doki
Nihon Geka Gakkai Zasshi|September 3, 2018
[THE AIM AND ROLE OF SURGERY TODAY]Yuichiro Doki
Nihon Geka Gakkai Zasshi|April 16, 2016
[PUBLICATION AND PAPER WRITING OF CLINICAL TRIALS]Yuichiro Doki
Annals of Thoracic and Cardiovascular Surgery : Official Journal of the Association of Thoracic and Cardiovascular Surgeons of Asia|June 24, 2011
Treatment of T4 esophageal cancer. Definitive chemo-radiotherapy vs chemo-radiotherapy followed by surgeryTomoki Makino, Yuichiro Doki
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 12, 2010
[Perspective of cancer treatment in new era]Yuichiro Doki, Morito Monden
Archives of Surgery (Chicago, Ill. : 1960)|August 23, 2012
The end of limited lymphadenectomy in gastroesophageal cancer surgery?: comment on "improving outcomes after gastroesophageal cancer resection"Yukinori Kurokawa, Yuichiro Doki
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 15, 2024
[The Power of the Gut Microbiome: Exploring New Perspectives in Colorectal Cancer Therapy]Mitsunobu Takeda, Yuichiro Doki
Journal of Gastroenterology|December 29, 2004
Can metallothionein be a useful molecular marker for selecting hepatocellular carcinoma patients for platinum-based chemotherapy?Yuichiro Doki, Morito Monden
Pageof 160

Showing results (1-10 of 1,594) with videos related to

Sort By:
Pageof 160
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 27, 2023
[The Fourth Basic Plan for Promotion of Cancer Control]Yuichiro Doki
Nihon Geka Gakkai Zasshi|August 19, 2015
[WORLD WIDE CLINICAL TRIALS FROM JAPAN]Yuichiro Doki
Surgery Today|February 17, 2016
Retraction Note: Notice of formal retraction of articles by Dr. Akihiro ChoYuichiro Doki
Nihon Geka Gakkai Zasshi|September 3, 2018
[THE AIM AND ROLE OF SURGERY TODAY]Yuichiro Doki
Nihon Geka Gakkai Zasshi|April 16, 2016
[PUBLICATION AND PAPER WRITING OF CLINICAL TRIALS]Yuichiro Doki
Annals of Thoracic and Cardiovascular Surgery : Official Journal of the Association of Thoracic and Cardiovascular Surgeons of Asia|June 24, 2011
Treatment of T4 esophageal cancer. Definitive chemo-radiotherapy vs chemo-radiotherapy followed by surgeryTomoki Makino, Yuichiro Doki
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 12, 2010
[Perspective of cancer treatment in new era]Yuichiro Doki, Morito Monden
Archives of Surgery (Chicago, Ill. : 1960)|August 23, 2012
The end of limited lymphadenectomy in gastroesophageal cancer surgery?: comment on "improving outcomes after gastroesophageal cancer resection"Yukinori Kurokawa, Yuichiro Doki
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 15, 2024
[The Power of the Gut Microbiome: Exploring New Perspectives in Colorectal Cancer Therapy]Mitsunobu Takeda, Yuichiro Doki
Journal of Gastroenterology|December 29, 2004
Can metallothionein be a useful molecular marker for selecting hepatocellular carcinoma patients for platinum-based chemotherapy?Yuichiro Doki, Morito Monden
Pageof 160